Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Perindopril × Clear all

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Heart Failure 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Cisplatin 455 Radiotherapy 333 Cyclophosphamide 317 Carboplatin 311 Paclitaxel 296 Capecitabine 292 Oxaliplatin 283 Docetaxel 274 Gemcitabine 269 Fluorouracil 246 apatinib 224 Drug Therapy 224 Bevacizumab 204 camrelizumab 186 Etoposide 176 Irinotecan 158 Doxorubicin 154 Dexamethasone 135 Leucovorin 133 Cytarabine 130 Blood Specimen Collection 128 pembrolizumab 122 Neoadjuvant Therapy 122 sintilimab 116 Pemetrexed 115 anlotinib 114 toripalimab 110 Rituximab 110 Surgical Procedures, Operative 109 S 1 (combination) 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡